A E Hay - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A E Hay

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Current Oncology (Toronto, Ont.)|May 3, 2019

The economic impact of the transition from branded to generic oncology drugsW Y Cheung, E A Kornelsen, N Mittmann, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2013

An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphomaA E Hay, B Klimm, B E Chen, et al.

Annals of Hematology|November 21, 2024

Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registryS Mathur, G Christou, R Delage, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Current Oncology (Toronto, Ont.)|May 3, 2019

The economic impact of the transition from branded to generic oncology drugsW Y Cheung, E A Kornelsen, N Mittmann, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2013

An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphomaA E Hay, B Klimm, B E Chen, et al.

Annals of Hematology|November 21, 2024

Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registryS Mathur, G Christou, R Delage, et al.

Pageof 2